Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular c

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:greenecho
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To analyze the influence factors and formation of extrahepatic collateral arteries (ECAs) in unresectable hepatocellular carcinoma (HCC) with or without chemoembolization.METHODS: Detailed histories of 35 patients with 39 ECAs of HCC and images including computerized tomography scan, digital subtraction angiography were reviewed carefully to identify ECAs of HCC, ECAs arising from, and anatomic location of tumors in liver. Tumor sizes were measured, and relations of EC As with times of chemoembolization, tumor size, and the anatomic tumor location were analyzed. Complications were observed after chemoembolization through ECAs of HCC with different techniques. RESULTS: Influence factors of formation of ECAs of HCC included the times of repeated chemoembolization, thelocation of tumors in liver, the tumor size and the types of chemoembolization. ECAs in HCC appeared after 3-4 times of chemoembolization (17.9%), but a higher frequency of ECAs occurred after 5-6 times of chemoembolization (56.4%). ECAs presented easily in peripheral areas (71.8%) of liver abutting to the anterior, posterior abdominal walls, the top right of diaphragm and right kidney.ECAs also occurred easily after complete obstruction of the trunk arteries supplying HCCs or the branches of proper hepatic arteries. Extrahepatic collaterals of HCC originated from right intal thoracic (mammary) artery (RITA, 5.1%), right intercostal artery (RICA, 7.7%), left gastric artery (LGA, 12.8%), right inferior phrenic artery (RIPA, 38.5%),omental artery (OTA, 2.6%), superior mesenteric artery (SMA, 23.1%), and right adrenal and renal capsule artery (RARCA, 10.3%), respectively. The complications after chemoembolization attributed to no super selective cathet erization.CONCLUSION: The formation of ECAs in unresectable HCCis obviously correlated with multiple chemoembolization,tumor size, types of chemoembolization, anatomic locationof tumors. Extrahepatic collaterals in HCC are corresponding to the tumor locations in liver.
其他文献
目的 探究和分析复方苦参注射液辅助放化疗治疗肿瘤的临床效果.方法 选择我院自2015年2月1日至2016年12月31日收治的120例肿瘤患者作为研究对象,根据患者的病种类型将其平均
患者男,81岁。因反复咳嗽、咳痰30年,加重伴呼吸困难,于2002年12月28日以慢性支气管炎急性发作、Ⅱ型呼吸衰竭、气管切开术后急诊收住院。住院后给予抗炎、解痉、平喘、化痰
目的:比较实施健康教育与否对老年高血压临床护理的效果.方法:对我院136例老年高血压患者随机分为对照组和健康教育组,每组68例,对照组患者给予内科常规护理,健康教育组患者
期刊
期刊
目的探讨红蓝光照射联合西黄胶囊治疗面部中重度寻常痤疮的疗效及对患者生活质量的影响。方法选取2014年11月至2016年7月山西省晋城煤业集团总医院收治的84例面部中重度寻常痤疮患者,根据治疗方案不同分为对照组与观察组,每组42例。对照组仅给予西黄胶囊治疗,观察组在此基础上加用红蓝光照射治疗,疗程均为1个月。比较两组患者治疗前后肿瘤坏死因子-α(TNF-α)、白介素-8(IL-8)的表达水平,采用生
期刊
目的 探讨小儿哮喘急性发作期肺炎支原体(MP)、肺炎衣原体(CP)感染血清学变化.方法 选择265例哮喘急性发作期患儿(哮喘组)和90例健康体检儿童(对照组),采用酶联免疫吸附法检测入选儿童血清中的肺炎支原体抗体(MP-IgM)、肺炎衣原体抗体(CP-IgM),按照阳性结果标准比较分析.结果 哮喘组MP阳性率为32.1%(85/265),CP阳性率为14.0%(37/265),均高于对照组的14.
目的:研究分析光固复合树脂用于治疗牙体病的临床疗效和安全性.方法:选择我院2018年3月~2019年3月在我院进行治疗的口腔科牙体病患者90例的102颗患牙作为研究对象,对所选研究
目的 研究阿卡波糖联合二甲双胍治疗2型糖尿病伴高血脂症的临床效果.方法 选取本院2017年9月-2018年9月收治的120例2型糖尿病伴高血脂症患者作为研究对象,将所选患者随机分为